tapered PVC-cuffed tracheal tubes
DevicePatients will be intubated with tapered-shape tracheal tubes
NCT Number: NCT01948635
The investigators hypothesized that PVC tapered-cuff tracheal tubes would reduce microaspiration of gastric content as determined by pepsin level in tracheal aspirate.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
ICU, Salengro Hospital, University Hospital of Lille, Lille, Nord, France
Microaspiration is the main route for entry of contaminated secretions into the lower respiratory tract of intubated critically ill patients. Tracheobronchial colonization might progress to ventilator-associated pneumonia (VAP) when the quantity and virulence of bacteria are high and when local and general host defenses are weak.
Recent in vitro and animal studies suggest that tapered-cuff tracheal tubes could be associated with reduced microaspiration of contaminated secretions and might be helpful in preventing VAP.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Patients will be intubated with tapered-shape tracheal tubes
Patients will be intubated with standard PVC cuffed tracheal tubes
Time frame: 48 hours after randomization
Mesuerment of pepsin level in tracheal aspirate will be used to quantify microaspiration of gastric contents
Time frame: 48 h after randomization
amylase level on tracheal aspirate would allow to quantify microaspiration of oropharyngeal secretions
Time frame: 28 days after randomization
Time frame: 28 days after randomization
University Hospital, Lille
Other
Acronym: BestCuff
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02389036
Critical Illness, Cross Infection
Sydney, New South Wales, Australia
View Trial DetailsNCT05972980
Critical Illness, Cross Infection
Torino, Italy
View Trial DetailsNCT07270939
Critical Illness, Cross Infection
View Trial DetailsNCT05591924
ARDS, Cognition Disorders
London, Ontario, Canada
View Trial Details